The B Cell Mutator AID Promotes B Lymphoid Blast Crisis and Drug Resistance in Chronic Myeloid Leukemia

被引:123
作者
Klemm, Lars [1 ,2 ,3 ]
Duy, Cihangir [1 ,2 ,3 ]
Iacobucci, Ilaria [4 ]
Kuchen, Stefan [5 ]
von Levetzow, Gregor [1 ,2 ,3 ]
Feldhahn, Niklas [3 ]
Henke, Nadine [3 ]
Li, Zhiyu [5 ]
Hoffmann, Thomas K. [3 ,8 ]
Kim, Yong-mi [1 ,2 ]
Hofmann, Wolf-Karsten [6 ]
Jumaa, Hassan [7 ]
Groffen, John [1 ,2 ]
Heisterkamp, Nora [1 ,2 ]
Martinelli, Giovanni [4 ]
Lieber, Michael R. [1 ]
Casellas, Rafael [5 ]
Mueschen, Markus [1 ,2 ,3 ]
机构
[1] Univ So Calif, Leukemia & Lymphoma Program, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90027 USA
[2] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA
[3] Univ Dusseldorf, D-40225 Dusseldorf, Germany
[4] Univ Bologna, Dept Hematol & Oncol L & A Seragnoli, I-40138 Bologna, Italy
[5] NIAMSD, NIH, Bethesda, MD 20892 USA
[6] Univ Heidelberg Hosp, Dept Hematol Oncol, D-68167 Mannheim, Germany
[7] Max Planck Inst Immunobiol, Freiburg, Germany
[8] Univ Duisburg Essen, Dept Otorhinolaryngol, D-45147 Essen, Germany
关键词
INDUCED CYTIDINE DEAMINASE; ACUTE LYMPHOBLASTIC-LEUKEMIA; KINASE DOMAIN MUTATIONS; ACTIVATION-INDUCED DEAMINASE; CLASS SWITCH RECOMBINATION; SOMATIC HYPERMUTATION; TYROSINE KINASE; DNA DEAMINATION; CHRONIC PHASE; C-MYC;
D O I
10.1016/j.ccr.2009.07.030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chronic myeloid leukemia (CIVIL) is induced by BCR-ABL1 and can be effectively treated for many years with Imatinib until leukemia cells acquire drug resistance through BCR-ABL1 mutations and progress into fatal B lymphoid blast crisis (LBC). Despite its clinical significance, the mechanism of progression into LBC is unknown. Here, we show that LBC but not CIVIL cells express the B cell-specific mutator enzyme AID. We demonstrate that AID expression in CIVIL cells promotes overall genetic instability by hypermutation of tumor suppressor and DNA repair genes. Importantly, our data uncover a causative role of AID activity in the acquisition of BCR-ABL1 mutations leading to Imatinib resistance, thus providing a rationale for the rapid development of drug resistance and blast crisis progression.
引用
收藏
页码:232 / 245
页数:14
相关论文
共 50 条
[21]   Deletions of Immunoglobulin heavy chain and T cell receptor gene regions are uniquely associated with lymphoid blast transformation of chronic myeloid leukemia [J].
Nacheva, Elisabeth P. ;
Brazma, Diana ;
Virgili, Anna ;
Howard-Reeves, Julie ;
Chanalaris, Anastasios ;
Gancheva, Katya ;
Apostolova, Margarita ;
Valganon, Mikel ;
Mazzullo, Helen ;
Grace, Colin .
BMC GENOMICS, 2010, 11
[22]   Molecular biomarkers of leukemia: convergence-based drug resistance mechanisms in chronic myeloid leukemia and myeloproliferative neoplasms [J].
Kaehler, Meike ;
von Bubnoff, Nikolas ;
Cascorbi, Ingolf ;
Gorantla, Sivahari Prasad .
FRONTIERS IN PHARMACOLOGY, 2024, 15
[23]   Very long survival in complete cytogenetic remission in an adolescent with lymphoid blast crisis of chronic myeloid leukemia after treatment with intensive ALL-directed chemotherapy combined with continuous imatinib [J].
Maschan, Alexey ;
Novichkova, Galina ;
Miakova, Natalia ;
Persiantseva, Marina .
PEDIATRIC BLOOD & CANCER, 2016, 63 (12) :2243-2245
[24]   Burkitt lymphoma in patients with chronic lymphocytic leukemia and other indolent B-cell lymphoid malignancies [J].
Robak, Tadeusz ;
Pluta, Agnieszka ;
Robak, Pawel ;
Janus, Agnieszka ;
Wawrzyniak, Ewa ;
Braun, Marcin .
LEUKEMIA & LYMPHOMA, 2025, 66 (08) :1376-1388
[25]   Sirtuin1 and Chronic Myeloid Leukemia: a Comprehensive Glance at Drug Resistance [J].
Abbasian, Sadegh ;
Shokrgozar, Negin ;
Tamaddon, Gholamhossein .
CLINICAL LABORATORY, 2021, 67 (05) :1110-1118
[26]   Coexistence of P190 and P210 BCR/ABL transcripts in chronic myeloid leukemia blast crisis resistant to imatinib [J].
Zhao Junmei ;
Yu Fengkuan ;
Song Yongping ;
Fang Baijun ;
Liu Yuzhang ;
Liu Lina ;
Zhang Qinglan .
SPRINGERPLUS, 2015, 4
[27]   Knock-down of Kaiso induces proliferation and blocks granulocytic differentiation in blast crisis of chronic myeloid leukemia [J].
Cofre, Jaime ;
Menezes, Joao R. L. ;
Pizzatti, Luciana ;
Abdelhay, Eliana .
CANCER CELL INTERNATIONAL, 2012, 12
[28]   Role of the B-cell receptor and the microenvironment in chronic lymphocytic leukemia [J].
Oppezzo, P. ;
Dighiero, G. .
BLOOD CANCER JOURNAL, 2013, 3 :e149-e149
[29]   Dasatinib as the salvage therapy for chronic myeloid leukemia with blast crisis and central nervous system involvement: A case report [J].
Lai, Shiue-Wei ;
Huang, Tzu-Chuan ;
Chen, Jia-Hong ;
Wu, Yi-Ying ;
Chang, Ping-Ying .
ONCOLOGY LETTERS, 2015, 9 (04) :1957-1961
[30]   Targeting B Cell Signaling in Chronic Lymphocytic Leukemia [J].
Arnason, Jon E. ;
Brown, Jennifer R. .
CURRENT ONCOLOGY REPORTS, 2017, 19 (09)